CROI 2024: HIV PrEP Update
Dr. Maria Corcorran discusses three key PrEP studies presented at the 2024 CROI (Conference on Retroviruses and Opportunistic Infections) in Denver, Colorado. The studies focused on estimating lifetime risk of HIV, the association between state-level PrEP coverage and state-level HIV diagnosis, and site-based HIV testing assay performance of two HIV PrEP medications. She also reviewed three presentations about novel formulations in the pipeline.